Back

Anti-IL5 monoclonal antibody treatment to rescue eosinophilic myocarditis in chronic eosinophilic leukemia: killing two birds with one stone.

28 August 2026 (13:30 - 13:45)
Organised by: Logo
Congress Presentation Part of: Cases of fulminant and immune-mediated myocarditis Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Caterina Menghi

University of Padua, Padova (Italy)

3 More presentations in this session

Presentation thumbnail
Steroid-refractory fulminant lymphocytic myocarditis successfully treated with tacrolimus guided by serial cardiovascular magnetic resonance
Doctor Y. Agata (Sapporo, JP)
Slides Video
Presentation thumbnail
Fulminant myocarditis due to H1N1 Influenza virus successfully managed with veno-arterial extracorporeal membrane oxygenation (VA-ECMO)
Doctor K. Talfanidou (Athens, GR)
Slides Video
Presentation thumbnail
Sequential fulminant myocarditis and guillain-barre syndrome following influenza A infection : a case report
Doctor A. Alshalawi (Riyadh, SA)
Slides Video

Access the full session

Session thumbnail
Cases of fulminant and immune-mediated myocarditis
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
When eosinophils mislead: diagnostic challenges in eosinophilic myocarditis with fluctuating peripheral eosinophilia
29 August 2026
thumbnail
Congress Session
Challenges in cardio-oncology (2)
31 August 2025
thumbnail
Congress Presentation
LV mass and hypereosinophilia
15 March 2025
thumbnail
Congress Presentation
Fulminant eosinophilic myocarditis and cardioembolic storm in steroid-refractory hypereosinophilic syndrome; navigating the thrombotic stage with targeted biologic therapy
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources